2515-8414

Therapeutic Advances in Ophthalmology

SAGE Publications

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 29 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact29 DOIs
2

Attach ORCID iDs across 18 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact18 DOIs
3

Deposit reference lists for 15 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact15 DOIs

DOIs for this ISSN

Showing the top 5 of 368 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Advances in retinal prosthesis systems (10.1177/2515841418817501)
ORCID
49.78 97
2 Corneal endothelial cell dysfunction: etiologies and managem… (10.1177/2515841418815802)
ORCID
49.09 91
3 Charles Bonnet Syndrome: so much more than just a side effec… (10.1177/2515841419886257)
Abstract References ORCID
35.78 2
4 The impact of COVID-19 pandemic on ophthalmology services: a… (10.1177/2515841420964099)
Abstract
34.51 23
5 Think sight loss, think Charles Bonnet syndrome (10.1177/2515841419895909)
Abstract
25.00 9
6 The impact of the COVID-19 pandemic on ophthalmology service… (10.1177/25158414211010549)
Abstract
22.58 7
7 Severity of diabetic retinopathy at the first ophthalmologic… (10.1177/2515841418791950)
ORCID
21.13 6
8 Bilateral acute depigmentation of iris: 3-year follow-up of… (10.1177/2515841418787988)
ORCID
17.47 4
9 Use of iris pattern recognition to evaluate ocular torsional… (10.1177/2515841418806492)
ORCID
15.05 3
10 Delleman–Oorthuys syndrome (oculocerebrocutaneous syndrome)… (10.1177/2515841418817486)
ORCID
15.05 3
11 Erratum in the article ‘Promising therapeutic drug delivery… (10.1177/2515841420970026)
Abstract ORCID
15.05 1
12 Corneal crosslinking in a case with Axenfeld–Rieger syndrome… (10.1177/2515841418822288)
ORCID
11.93 2
13 Management of anti-VEGF intravitreal treatment at University… (10.1177/2515841420966861)
Abstract
11.93 2
14 Response to ‘Clinical features, optical coherence tomography… (10.1177/2515841421992230)
Abstract
11.93 2
15 The effect of amblyopia on balance and gait (10.1177/25158414221141380)
Abstract
11.93 2
16 Plain language summary of publication of the 48-week results… (10.1177/25158414251356388)
References
7.53 1
17 Targeting retinal angiogenesis: sex differences in adverse r… (10.1177/25158414251359587)
Abstract
7.53 1
18 Charles Bonnet syndrome: taking another look at visual hallu… (10.1177/25158414251359588)
Abstract
7.53 1
19 Introducing <i>Therapeutic Advances in O… (10.1177/2515841418774422)
Abstract References ORCID
0.00 0
20 An imaging-based treatment algorithm for posterior focal ret… (10.1177/2515841418774423)
0.00 4
21 Regenerative medicine in the retina: from stem cells to cell… (10.1177/2515841418774433)
0.00 34
22 Women in Vision UK strive for gender equality in ophthalmolo… (10.1177/2515841418774434)
Abstract ORCID
0.00 0
23 Low vision services: a practical guide for the clinician (10.1177/2515841418776264)
0.00 24
24 An eye for azithromycin: review of the literature (10.1177/2515841418783622)
0.00 23
25 Visual and vestibular functioning, and age and surgery effec… (10.1177/2515841418788005)
0.00 3
26 A rare case of bilateral spontaneous indirect caroticocavern… (10.1177/2515841418788303)
0.00 6
27 Analysis of basal and reflex human tear osmolarity in normal… (10.1177/2515841418794886)
0.00 8
28 Efficacy of oral rifampicin in chronic central serous chorio… (10.1177/2515841418807130)
0.00 6
29 DUO: an innovative multidrug delivery system (10.1177/2515841418812061)
Abstract ORCID
0.00 0
30 Comparison of endothelial/Descemet’s membrane complex thickn… (10.1177/2515841418814187)
0.00 3
31 Choroideremia: from genetic and clinical phenotyping to gene… (10.1177/2515841418817490)
0.00 36
32 Unexpected visual improvement after aborted intracorneal rin… (10.1177/2515841418817500)
ORCID
0.00 0
33 Dexamethasone implant for immunogammopathy maculopathy assoc… (10.1177/2515841418820441)
0.00 8
34 Long-term management of non-ischemic central retinal vein oc… (10.1177/2515841418820755)
0.00 10
35 Embedded deep learning in ophthalmology: making ophthalmic i… (10.1177/2515841419827172)
0.00 24
36 Comparison of the clinical estimation of cup-to-disk ratio b… (10.1177/2515841419827268)
0.00 3
37 Polypoidal choroidal vasculopathy: a comprehensive clinical… (10.1177/2515841419831152)
0.00 24
38 The role of optical coherence tomography in therapeutics and… (10.1177/2515841419831155)
0.00 6
39 Visual rehabilitation using video game stimulation for Starg… (10.1177/2515841419831158)
0.00 7
40 Crude and standardized prevalences of cataract and related f… (10.1177/2515841419835339)
0.00 4
41 RNA-sequencing in ophthalmology research: considerations for… (10.1177/2515841419835460)
0.00 4
42 Comparison of rebound tonometry and non-contact airpuff tono… (10.1177/2515841419835731)
0.00 11
43 Unilateral cilioretinal artery occlusion following cannabis… (10.1177/2515841419838661)
0.00 1
44 Reviving the lost art of scleral buckling surgery for rhegma… (10.1177/2515841419838662)
0.00 0
45 Direct transretinal removal of subfoveal perfluorocarbon liq… (10.1177/2515841419840244)
0.00 2
46 An overview of optical coherence tomography angiography and… (10.1177/2515841419840249)
0.00 26
47 Orbital relapse of retinoblastoma in patients with high-risk… (10.1177/2515841419844080)
0.00 2
48 Syringocystadenocarcinoma papilliferum with orbital invasion… (10.1177/2515841419844087)
0.00 5
49 The correlation of routine hematological indices with pteryg… (10.1177/2515841419848922)
0.00 3
50 Recurrent retinal and choroidal ischemia in a case of ocular… (10.1177/2515841419848926)
0.00 2